Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Impact of Molecular Markers and Cytogenetic Abnormalities on Long-Term Overall Survival and Disease-Free Survival after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Acute Myeloid Leukemia (AML) patients

Mauricette Michallet, MD, PhD, Mohamad Sobh, PhD, Xavier Thomas, MD, Carole Charlot, Fiorenza Barraco, MD, Giovanna Cannas, MD, Franck E Nicolini, MD, PhD, Emmanuelle Nicolas-virelizier, MD, Claudiu Plesa, MD, Youcef Chelghoum, MD, Jacques Troncy, MD, jean-Pierre Magaud, MD, PhD, Isabelle Tigaud, Sandrine Hayette

Blood (2008) 112 (11): 4476.

https://doi.org/10.1182/blood.V112.11.4476.4476

Published: 2008

Journal Articles

Mir-21 Is Over Expressed in Aggressive SMZL

Marie Bouteloup, Aurélie Verney, Lucile Baseggio, PhD, Evelyne Callet-Bauchu, MD, PhD, Pascale Felman, MD, Martine Ffrench, MD, PhD, Bertrand Coiffier, MD, Jean-Pierre Magaud, MD, PhD, Francoise Berger, MD, PhD, Gilles Andre Salles, MD, PhD, Alexandra Traverse-Glehen, MD, PhD

Blood (2008) 112 (11): 624.

https://doi.org/10.1182/blood.V112.11.624.624

Published: 2008

Journal Articles

Detection of Twelve Nucleotides Instertion in the BCR-ABL Kinase Domain in an Imatinib-Resistant but Dasatinib-Sensitive Patient with Bi-Phenotypic Acute Leukemia.

Sandrine Hayette, PhD, Kaddour Chabane, BSc, Andrei Tchirkov, MD, PhD, Marc G Berger, MD, PhD, jean-Pierre Magaud, MD, PhD, Franck E Nicolini, MD, PhD, Olivier Tournilhac, MD, PhD

Blood (2008) 112 (11): 1615.

https://doi.org/10.1182/blood.V112.11.1615.1615

Published: 2008

Journal Articles

Pharmacogenomic Factors Such as the Expression of Imatinib Transporters (OCT-1, ABCB-1 and ABCG-2) at Diagnosis, OCT-1 SNPs, and Steady-State Imatinib and Desmethyl-Imatinib Trough Plasma Levels in De Novo Chronic Phase Chronic Myelogenous Leukemia, May Influence Disease Response to Imatinib

Hélène Labussière, MD, Sandrine Hayette, PhD, Kaddour Chabane, BSc, Marie-Claude Gagnieu, PharmD, Quoc-Hung Lê, MD, PhD, Isabelle Tigaud, MD, Joëlle Bernard, BSc, Fiorenza Barraco, MD, Jean-Pierre Magaud, MD, PhD, Mauricette Michallet, MD, PhD, Franck E Nicolini, MD, PhD

Blood (2008) 112 (11): 2643.

https://doi.org/10.1182/blood.V112.11.2643.2643

Published: 2008

Journal Articles

Usefulness of CD10 Study by Multi-Colour Flow Cytometry in Angioimmunoblastic T-Cell Lymphoma.

Lucile Baseggio, PhD, Francoise Berger, MD-PhD, Josiane Carret, Catherine Thieblemont, MD, Dominique Morel, Jean-Pierre Magaud, MD-PhD, Pascale Felman, MD

Blood (2004) 104 (11): 4545.

https://doi.org/10.1182/blood.V104.11.4545.4545

Published: 2004

NARROW

Impact of Molecular Markers and Cytogenetic Abnormalities on Long-Term Overall Survival and Disease-Free Survival after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Acute Myeloid Leukemia (AML) patients

Mir-21 Is Over Expressed in Aggressive SMZL

Detection of Twelve Nucleotides Instertion in the BCR-ABL Kinase Domain in an Imatinib-Resistant but Dasatinib-Sensitive Patient with Bi-Phenotypic Acute Leukemia.

Pharmacogenomic Factors Such as the Expression of Imatinib Transporters (OCT-1, ABCB-1 and ABCG-2) at Diagnosis, OCT-1 SNPs, and Steady-State Imatinib and Desmethyl-Imatinib Trough Plasma Levels in De Novo Chronic Phase Chronic Myelogenous Leukemia, May Influence Disease Response to Imatinib

Usefulness of CD10 Study by Multi-Colour Flow Cytometry in Angioimmunoblastic T-Cell Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

Impact of Molecular Markers and Cytogenetic Abnormalities on Long-Term Overall Survival and Disease-Free Survival after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Acute Myeloid Leukemia (AML) patients

Mir-21 Is Over Expressed in Aggressive SMZL

Detection of Twelve Nucleotides Instertion in the BCR-ABL Kinase Domain in an Imatinib-Resistant but Dasatinib-Sensitive Patient with Bi-Phenotypic Acute Leukemia.

Pharmacogenomic Factors Such as the Expression of Imatinib Transporters (OCT-1, ABCB-1 and ABCG-2) at Diagnosis, OCT-1 SNPs, and Steady-State Imatinib and Desmethyl-Imatinib Trough Plasma Levels in De Novo Chronic Phase Chronic Myelogenous Leukemia, May Influence Disease Response to Imatinib

Usefulness of CD10 Study by Multi-Colour Flow Cytometry in Angioimmunoblastic T-Cell Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only